As the nation’s largest private funder of pancreatic cancer research, we recognize that not only are we a voice in the national dialogue on the need for earlier detection and better therapies for pancreatic cancer; we started the conversation. We have the profound responsibility of shining a spotlight on pancreatic cancer and doing everything possible to improve the treatment of the disease by funding leading-edge research.
For the researchers in laboratories across the country, the clinicians on the front lines of treatment, the patients and their loved ones facing this life-threatening disease with tenacity and grace, we are singularly focused on changing patient outcomes which can only be achieved through research.